Europe « Science and Enterprise

Trial Shows Vaccine Induces Chikungunya Immune Response

By Alan, on August 7th, 2023%

Initial findings from a large clinical trial testing a vaccine against the chikungunya virus show the vaccine generates protective antibodies in the vast majority of recipients. . . . → Read More: Trial Shows Vaccine Induces Chikungunya Immune Response

Trial Advances of Dual-Action Cancer Immunotherapy

By Alan, on August 3rd, 2023%

A clinical trial assessing a synthetic antibody to generate an immediate response and also generate a more durable treatment for solid tumor cancers, advanced to a mid-stage study. . . . → Read More: Trial Advances of Dual-Action Cancer Immunotherapy

Companies Partner on Fast Production of Biologics in Plants

By Alan, on August 1st, 2023%

The developer of a biologic drug-making process with engineered plant crops is collaborating with a vertical farming company to create a network of biologics production facilities. . . . → Read More: Companies Partner on Fast Production of Biologics in Plants

Digital Biomarkers Shown to Highlight Parkinson’s Disease

By Alan, on July 7th, 2023%

MRI image of white matter fibers in the brain

Early findings indicate calculations from MRI scans of white matter lesions in the brain can distinguish between Parkinson’s disease and other neurological conditions. . . . → Read More: Digital Biomarkers Shown to Highlight Parkinson’s Disease

Biotech Start-Up to Discover Cystic Fibrosis Therapy

By Alan, on June 19th, 2023%

A new biotechnology company is advancing research to find a comprehensive treatment for cystic fibrosis, and staked to a €2 million seed investment from its founder. . . . → Read More: Biotech Start-Up to Discover Cystic Fibrosis Therapy

Crispr Therapy Shown to Reduce Harmful Gut Microbes

By Alan, on May 31st, 2023%

A clinical trial shows an oral therapy with engineered viruses delivers precise gene-edited payloads to reduce E. coli communities in the gut with no serious adverse effects. . . . → Read More: Crispr Therapy Shown to Reduce Harmful Gut Microbes

AI-Designed Cancer Vaccine Shown to Act Against Melanoma

By Alan, on May 26th, 2023%

Results of a small clinical trial show most patients with melanoma receiving a personalized therapeutic vaccine with an approved immunotherapy reduced at least some of their tumors. . . . → Read More: AI-Designed Cancer Vaccine Shown to Act Against Melanoma

Pharma Company Gains Precise Gene Edits in $2B Biotech Deal

By Alan, on May 24th, 2023%

A global drug maker is acquiring access to a biotechnology company’s precise genome editing techniques to develop new therapies for rare and cardiometabolic disorders. . . . → Read More: Pharma Company Gains Precise Gene Edits in $2B Biotech Deal

Rare Disease Search Adds Large Language Model A.I.

By Alan, on May 15th, 2023%

A company offering a search engine to help diagnose rare diseases is integrating generative models from Open AI into its artificial intelligence algorithms. . . . → Read More: Rare Disease Search Adds Large Language Model A.I.

Quantum Technology Start-Up Accelerator Unveiled

By Alan, on May 11th, 2023%

A business incubator is underway to help start-up enterprises in Denmark working in quantum technologies, particularly with defense-related applications. . . . → Read More: Quantum Technology Start-Up Accelerator Unveiled

Subscribe for email alerts

Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Like us on Facebook

Specials

Guest Posts

Please share Science & Enterprise